Neurocrine Biosciences (NASDAQ:NBIX) Stock Price Expected to Rise, Morgan Stanley Analyst SaysMarket Beat·2 days ago, 06:12 PMNBIX-0.22%
Neurocrine Chief Commercial Officer Eric Benevich disposes of 2,154 common shares worth $333,428.94PUBT·Sep 11 at 12:29 AMNBIX-0.22%
NBIX: Multi-product growth, robust pipeline, and strategic adaptation position for long-term successQuartr·Sep 10 at 02:08 PMNBIX-0.22%
Neurocrine Biosciences' (NBIX) "Outperform" Rating Reiterated at Royal Bank Of CanadaMarket Beat·Sep 8 at 03:24 PMNBIX-0.22%
Neurocrine Biosciences, Inc. (NASDAQ:NBIX) Given Average Recommendation of "Moderate Buy" by AnalystsMarket Beat·Sep 7 at 06:29 AMNBIX-0.22%BLK+1.62%
Neurocrine Biosciences executives to speak at Wells Fargo healthcare conferencePUBT·Sep 2 at 08:01 PMNBIX-0.22%
The Barbell Strategy of 2026: From Tech Moats to Defensive YieldsGlobal Report·Sep 1 at 10:12 AMNXPI+4.48%KDK-1.58%
Reality Check: The Moneymakers, the Hype Hustlers, and the Cash BurnersGlobal Report·Aug 25 at 10:12 AMCRMD-1.70%BAX-1.57%
10 Health Care Stocks Whale Activity In Today’s Sessionbenzinga_article·Aug 21 at 05:35 PMBSX-0.28%HIMS+0.26%
Advisors Preferred LLC Invests $5.42 Million in Neurocrine Biosciences, Inc. $NBIXMarket Beat·Aug 21 at 07:20 AMNBIX-0.22%
Jim Cramer Says Buy Uber, Calls Rockwell Automation 'One Ugly Chart' but a 'Great Long-Term Situation'benzinga_article·Aug 18 at 12:12 PMUBER-1.23%ROK+1.67%
14,787 Shares in Neurocrine Biosciences, Inc. $NBIX Purchased by ABN AMRO Bank N.V.Market Beat·Aug 16 at 07:04 AMNBIX-0.22%
Neurocrine Biosciences, Inc. (NASDAQ:NBIX) Given Consensus Rating of "Moderate Buy" by BrokeragesMarket Beat·Aug 13 at 06:29 AMNBIX-0.22%
